Vaccine for Children

RECOVERY - Delivery Order Notification THIS NOTICE IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY UNDER THE AMERICAN RECOVERY AND REINVESTMENT ACT PROGRAM. The Centers for Disease Control and Prevention (CDC) intends to issue a delivery order against an Indefinite Delivery Indefinite Quantity Contract 200-2009-29370 to Merck and Co., Inc. for the following Vaccines: Vaccine January February March Est Value Doses Est Value Doses Est Value Doses Varivax® $ 220,362 3,415 $ 401,099 6,216 $ 464,986 7,206 VAQTA® $ 17,987 1,384 $ 13,665 1,051 $ 14,312 1,101 MMRII® $ 23,263 1,271 $ 16,167 883 $ 16,614 908 RotaTeq® $ 14,514 254 $ 14,733 258 $ 15,173 265 Gardasil® $ 361,581 3,425 $ 331,037 3,135 $ 368,930 3,494 Pneumovax® $ 27,812 963 $ 27,234 943 $ 30,960 1,072 RECOMBIVAX HB® $ 7,575 758 $ 7,623 762 $ 7,718 772 Total $ 673,094 11,469 $ 811,558 13,249 $ 918,693 14,818 The delivery order will be funded through the American Recovery and Reinvestment Act of 2009. This opportunity is available only to contractor Merck & Co under Contract Number 200-2009-29370 which was previously competed and awarded in March 2009. This is not a request for competitive proposals, nor is a solicitation available. This notice is provided for informational purposes under the American Recovery and Reinvestment Act (ARRA) Program. Any questions regarding this notice must be submitted in writing to Berta Biltz at [email protected] .